Retrospects and prospects of transjugular intrahepatic portosystemic shunt in China / 临床肝胆病杂志

ABSTRACT

In recent years, transjugular intrahepatic portosystemic shunt (TIPS) has been gradually applied and widely accepted in China, and the technical standards, indications, and contraindications of this technique have also been established gradually. The invention of covered stents successfully solved the issue of a high rate of shunt occlusion seen in bare stents, and thus TIPS is greatly developed. Unfortunately, since most clinical studies were published before the invention of covered stents, the clinical effect of TIPS cannot represent the current status in this field. With the development of this technique, the indications for TIPS are gradually expanded, and as a country with many patients in need of TIPS, high-quality multicenter randomized controlled clinical trials are urgently needed in China. TIPS has been accepted in the treatment of various complications of portal hypertension and hepatic vascular diseases and will enjoy a promising future.